Stock TKUN TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Tikun Olam-Cannbit Pharmaceuticals Ltd Stock TEL AVIV STOCK EXCHANGE

Equities

TKUN

IL0010843675

Pharmaceuticals

Financials

Sales 2022 49.3 185.12 Sales 2023 44.23 166.08 Capitalization 25.49M 95.71M
Net income 2022 -48M -180M Net income 2023 -88M -330M EV / Sales 2022 1,234,605 x
Net Debt 2022 17.5M 65.72M Net Debt 2023 13.42M 50.39M EV / Sales 2023 879,698 x
P/E ratio 2022
-0.97 x
P/E ratio 2023
-0.22 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 65.07%
More Fundamentals * Assessed data

Chart Tikun Olam-Cannbit Pharmaceuticals Ltd

Dynamic Chart

Latest news about Tikun Olam-Cannbit Pharmaceuticals Ltd

Tikun Olam-Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tikun Olam-Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tikun Olam-Cannbit Pharmaceuticals Ltd Auditor Raises 'Going Concern' Doubt CI
Tikun Olam-Cannbit Pharmaceuticals Ltd and Ambrosia-Supherb Signs an Exclusive Partnership Agreement CI
Tikun Olam - Cannbit Pharmaceuticals Ltd Signs an Agreement with Maccabi Healthcare Services CI
Tikun Olam-Cannbit and Gynica Announce Start of A Joint Clinical Study CI
Apex Capital Markets Ltd. acquired 23.5% stake in A.L. Capital Holdings Ltd (TASE:CPHO-M) from Apex Issuances, Investment arm for ILS 0.5 million. CI
More news

Press releases Tikun Olam-Cannbit Pharmaceuticals Ltd

Tikun Olam Cannbit Pharmaceuticals : Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel - Evogene AQ
Tamir Fishman Venture Capital II : Eucalyptus Growth Capital fund to raise $300M for late-stage Israeli companies, 12.05.15 PU
Tamir Fishman Venture Capital II : Capital soars after court ruling against Teva, 28.04.15 PU
Tamir Fishman Venture Capital II : Dadi Perlmutter, Rami Hadar & Tamir-Fishman Form a Partnership and Plan to Raise 300M$, 12.05.15 PU
More press releases

Managers and Directors - Tikun Olam-Cannbit Pharmaceuticals Ltd

Managers TitleAgeSince
Ifat Kariv CEO
 Chief Executive Officer 50 -
Daniel Spira AUD
 Comptroller/Controller/Auditor 69 -
Members of the board TitleAgeSince
Revital Aviram BRD
 Director/Board Member 66 15-02-14
Erez Navon BRD
 Director/Board Member 50 -
Ifat Kariv CEO
 Chief Executive Officer 50 -
More insiders

Company Profile

Tikun Olam Cannbit Pharmaceuticals Ltd, formerly Cannbit Pharmaceuticals Ltd, is an Israel-based company that produces medical cannabis. The Company engages in growing and cultivating medical cannabis products.
Sector
Pharmaceuticals
More about the company

Sector Recreational Pharmaceuticals

1st Jan change Capi.
CURALEAF HOLDINGS, INC. Stock Curaleaf Holdings, Inc.
+22.87% 3.62B
TRULIEVE CANNABIS CORP. Stock Trulieve Cannabis Corp.
+115.18% 2.09B
ACREAGE HOLDINGS, INC. Stock Acreage Holdings, Inc.
+284.62% 55.7M
Recreational Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TKUN Stock
  4. TKUN Stock